GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Abcc3 | affects expression | ISO | Abcc3 (Mus musculus) | 6480464 | CTD | Deoxycholic Acid affects the expression of ABCC3 mRNA | PMID:21914718 | Abcc3 | decreases expression | ISO | Abcc3 (Mus musculus) | 6480464 | CTD | Deoxycholic Acid results in decreased expression of ABCC3 mRNA | PMID:25582706 | Abcc3 | increases activity | ISO | ABCC3 (Homo sapiens) | 6480464 | CTD | Deoxycholic Acid results in increased activity of ABCC3 protein | PMID:17569508 | Abcc3 | increases expression | ISO | ABCC3 (Homo sapiens) | 6480464 | CTD | Deoxycholic Acid results in increased expression of ABCC3 mRNA | PMID:25055961 | Abcc3 | multiple interactions | ISO | ABCC3 (Homo sapiens) | 6480464 | CTD | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ABCC3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of ABCC3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of ABCC3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCC3 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ABCC3 mRNA | PMID:32152650 PMID:33819548 | Abcc3 | multiple interactions | ISO | Abcc3 (Mus musculus) | 6480464 | CTD | SLCO1A1 protein affects the susceptibility to [Deoxycholic Acid affects the expression of ABCC3 mRNA] | PMID:21914718 | |
Go Back to source page | Continue to Ontology report |